ROMA Calculator vs Simsei Portal

ROMA (Risk of Ovarian Malignancy Algorithm) is an FDA cleared algorithm presented in mobile application. The application is intended for educational purposes only by clinicians, who are trained in using ROMA. This application was developed by AbiTech, Inc. on the behalf of the University of Rochester Wilmont Cancer Institute. The ROMA algorithm is trademarked by Roche, and was developed by Dr. Richard Moore, MD, at the University of Rochester. UR Medicine’s Wilmot Cancer Institute (WCI) features an 84-bed cancer center with 11 outpatient locations throughout the Rochester and Finger Lakes region. Wilmot, a component of Strong Memorial Hospital, offers patients and their families comprehensive services including one of upstate New York’s largest blood and marrow transplant programs and the Rochester area’s only ACOS-accredited breast cancer center. Wilmot is home to the region’s first survivorship clinic and offers clinical trials of new therapies and options that may not be available anywhere else upstate. In addition, Wilmot includes a team of scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care.

The Simsei® Portal allows you to assess resident’s surgical skills. Simsei Simulation was developed by Applied Medical as a result of the company’s founding purpose to improve patient outcomes through the delivery of affordable, accessible and high-quality healthcare solutions. We maintain that surgical education, developed in close collaboration with the surgical community, is critical to advancing skills and improving clinical outcomes. Built on a solid foundation of best practices, Simsei Simulation strives to enhance education content, processes and retention. Through competency-based methods, Simsei Simulation facilitates knowledge, skill and attitude adoption, with the goal of improving the efficiency and effectiveness of simulation-based surgical education programs, and ultimately improving patient care.